These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7721232)
41. Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging. Dollé F; Hinnen F; Valette H; Fuseau C; Duval R; Péglion JL; Crouzel C Bioorg Med Chem; 1997 Apr; 5(4):749-64. PubMed ID: 9158874 [TBL] [Abstract][Full Text] [Related]
42. Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968. Randle JC; Lombet A; Nagel N; Abraham C; Aptel H; Peglion JL; Renaud JF Eur J Pharmacol; 1990 Nov; 190(1-2):85-96. PubMed ID: 1706275 [TBL] [Abstract][Full Text] [Related]
43. Effects of aranidipine, a novel calcium channel blocker, on mechanical responses of the isolated rat portal vein: comparison with typical calcium channel blockers and potassium channel openers. Okumura K; Ichihara K; Nagasaka M J Cardiovasc Pharmacol; 1997 Feb; 29(2):209-15. PubMed ID: 9057070 [TBL] [Abstract][Full Text] [Related]
44. The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits. Morel N; Buryi V; Feron O; Gomez JP; Christen MO; Godfraind T Br J Pharmacol; 1998 Nov; 125(5):1005-12. PubMed ID: 9846638 [TBL] [Abstract][Full Text] [Related]
45. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium. Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893 [TBL] [Abstract][Full Text] [Related]
46. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. Williams LT; Tremble P J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site. Kwan YW; Bangalore R; Lakitsh M; Glossmann H; Kass RS J Mol Cell Cardiol; 1995 Jan; 27(1):253-62. PubMed ID: 7760349 [TBL] [Abstract][Full Text] [Related]
48. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins. Dunn SM; Bladen C Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998 [TBL] [Abstract][Full Text] [Related]
49. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery. Morel N; Godfraind T Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351 [TBL] [Abstract][Full Text] [Related]
50. The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site. Zobrist RH; Giacomini KM; Nelson WL; Giacomini JC J Mol Cell Cardiol; 1986 Sep; 18(9):963-74. PubMed ID: 3783730 [TBL] [Abstract][Full Text] [Related]
51. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog. Drieu la Rochelle CD; Grosset A; O'Connor SE Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724 [TBL] [Abstract][Full Text] [Related]
52. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes. Guerra L; Cerbai E; Gessi S; Borea PA; Mugelli A Br J Pharmacol; 1996 Jul; 118(5):1278-84. PubMed ID: 8818354 [TBL] [Abstract][Full Text] [Related]
53. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity. Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820 [TBL] [Abstract][Full Text] [Related]
54. Effects of oxodipine on 45Ca movements and contractile responses in vascular smooth muscle. Tamargo J; Tejerina T Br J Pharmacol; 1989 Jun; 97(2):339-46. PubMed ID: 2758219 [TBL] [Abstract][Full Text] [Related]
55. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307 [TBL] [Abstract][Full Text] [Related]
56. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine. Mennini T; Taddei C; Uslenghi A; Cagnotto A; Micheli D; Trist D; Gaviraghi G; Ratti E J Pharm Pharmacol; 1993 May; 45(5):430-3. PubMed ID: 8099961 [TBL] [Abstract][Full Text] [Related]
57. Ca2+ channels in chick neural retina cells characterized by 1,4-dihydropyridine antagonists and activators. Wei XY; Rutledge A; Zhong Q; Ferrante J; Triggle DJ Can J Physiol Pharmacol; 1989 May; 67(5):506-14. PubMed ID: 2548693 [TBL] [Abstract][Full Text] [Related]
58. A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats. Yamada S; Matsuoka Y; Kato Y; Kimura R; Inagaki O J Pharmacol Exp Ther; 1992 Aug; 262(2):589-94. PubMed ID: 1323654 [TBL] [Abstract][Full Text] [Related]
59. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists. Eltze M; Boer R; Sanders KH; Boss H; Ulrich WR; Flockerzi D Chirality; 1990; 2(4):233-40. PubMed ID: 1964575 [TBL] [Abstract][Full Text] [Related]
60. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding. Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]